Paxlovid

• B.C. becomes 1st province in Canada to pay for Paxlovid

  The federal government has told all provinces they will no longer be paying for the drug used to treat COVID-19. Other provinces are moving the drug to the pharmacare program.

  Health

  May 30, 2024
  
• Canada enters 5th year of COVID-19. Are we falling short in treatment?

  As Canada enters its fifth year navigating COVID-19, treatment options for the virus remain disappointingly inadequate, according to advocates and experts.

  Health

  Dec 26, 2023
  
• Advertisement
• Some COVID-19 treatments in U.S. are about to get expensive. Here’s why

  Pharmaceutical giant Pfizer is setting the price for a five-day treatment of Paxlovid at $1,390, but Americans can still access the pills at no cost -- for now.

  Health

  Oct 27, 2023
• Advertisement
• Paxlovid slashed severe outcomes for at-risk patients after Omicron surge, study finds

  Canadians at risk of severe illness from COVID-19 who took Paxlovid had a significantly lower risk of being hospitalized or dying as a result of the virus, a new study shows.

  Health

  Feb 13, 2023
• Ontario pharmacists can prescribe for 13 common ailments as of Jan. 1

  The province's ministry of health issued a reminder of the previously announced move on Wednesday, noting the service will be free with a health card.

  Canada

  Dec 28, 2022
• Ontario pharmacists allowed to prescribe Paxlovid for COVID-19 treatment

  Ontario's health minister Sylvia Jones said pharmacists can prescribe Paxlovid to treat severe cases of COVID-19 at no cost to the patient starting on Monday, Dec. 12.

  Health

  Dec 8, 2022
• Ontario considering letting pharmacists prescribe Paxlovid for COVID-19: Moore

  Ontario is considering allowing pharmacists to prescribe the COVID-19 treatment drug Paxlovid in order to expand access, the province's top doctor says.

  Health

  Nov 6, 2022
• Alberta awaiting further ‘guidance’ on Health Canada-approved COVID-19 treatment

  Evusheld is currently only available in Alberta for the prevention of COVID-19 but was also recently approved as a treatment.

  Canada

  Oct 25, 2022
• Advertisement
• U.S. FDA orders Pfizer to test 2nd Paxlovid course for rebound COVID patients

  The U.S. FDA has ordered Pfizer Inc PFE.N to test the effects of an additional course of its antiviral Paxlovid among people who experience a rebound in COVID-19 after treatment

  Health

  Aug 19, 2022
• Advertisement
• What is COVID-19 rebound and when does it happen? Here’s what we know

  President Joe Biden tested positive for COVID-19 a third time after taking an anti-viral drug treatment, but an expert says "rebound" cases are not an unheard phenomenon.

  Health

  Aug 5, 2022